Almost 200 Covid-19 vaccine candidates are currently being developed. However, only a tiny percentage of these will ever be mass-produced and distributed. Concerns around ‘vaccine nationalism’ have grown, as high-income countries pre-order hundreds of millions of vaccine doses. This article looks at this problem and examines what solutions are being put in place to ensure low and middle income countries receive adequate supplies of any successful Covid-19 vaccine.

Scientific research in universities is funded through a mix of public money, EU funding and other sources. This article considers the House of Lords Science and Technology Committee report on the pressures on science research funding in universities, including proposals in the Augar Review to lower the existing cap on tuition fees and the potential impact of Brexit. The committee’s report is due to debated in the House of Lords on 9 September 2020.